SEL-302

N/A

Report date: 2024/09/25 20:00:35

Base Information

Drug NameSEL-302
Drug Alias NameSEL-302
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV8 vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsMethylmalonic acidaemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSelecta Biosciences IncAskBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAskBio IncSelecta Biosciences Inc
Active IndicationsN/A
Inactive IndicationsMethylmalonic acidaemia

Other Information

ATC CodeN/A
Related LinksN/A